EARNINGS & TRADING: Nexus Infrastructure first-half loss narrows
The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 0.21p on 24-07-2026 at 18:35:10 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.22p |
| Sell | 0.20p |
| Last Trade: | Buy 60,000.00 at 0.2125p |
| Day's Volume: | 5,771,282 |
| Last Close: | 0.21p |
| Open: | 0.21p |
| ISIN: | GB00BSVYN304 |
| Day's Range | 0.21p - 0.21p |
| 52wk Range: | 0.18p - 0.265p |
| Market Capitalisation: | £4.51m |
| VWAP: | 0.206437p |
| Shares in Issue: | 2.15b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Theracryf PLC (TCF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 60,000 | 0.2125p | Ordinary |
13:15:54 - 24-Jul-26 |
| Buy* | 2,210,117 | 0.2125p | Ordinary |
12:51:24 - 24-Jul-26 |
| Buy* | 500 | 0.22p | Ordinary |
10:15:17 - 24-Jul-26 |
| Buy* | 665 | 0.22p | SI Trade |
10:15:17 - 24-Jul-26 |
| Unknown* | 3,500,000 | 0.2025p | Ordinary |
08:07:30 - 24-Jul-26 |
| Sell* | 7,000 | 0.2025p | Ordinary |
08:44:26 - 23-Jul-26 |
| Buy* | 696,283 | 0.215p | Ordinary |
08:01:44 - 23-Jul-26 |
| Sell* | 819 | 0.20p | Ordinary |
08:01:29 - 23-Jul-26 |
| Sell* | 126,889 | 0.2025p | Ordinary |
15:35:43 - 22-Jul-26 |
| Buy* | 1,484 | 0.22p | Ordinary |
13:41:05 - 22-Jul-26 |
Theracryf PLC (TCF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 24th Jun 2026 4:34 pm | RNS | Holding(s) in Company |
| 26th May 2026 2:40 pm | RNS | Holding(s) in Company |
| 15th May 2026 12:43 pm | RNS | Holding(s) in Company |
| 15th May 2026 7:00 am | RNS | Holding(s) in Company |
| 14th May 2026 7:00 am | RNS | Positive Ox-1 tox data in addiction programme |
| 21st Apr 2026 7:00 am | RNS-R | Investor Webinar |
| 20th Apr 2026 7:00 am | RNS | Successful GMP Manufacture Advances Ox-1 to Clinic |
| 16th Apr 2026 7:00 am | RNS | New Manufacturing Process Patent for Ox-1 |
| 14th Apr 2026 7:00 am | RNS | Non-Binding Proposal to Acquire TheraCryf’s Assets |
| 23rd Mar 2026 7:00 am | RNS | Ox-1 Programme Advances to Final Toxicology Study |